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Abstract
The expression of the myogenic regulatory factors (MRFs), Myf5, MyoD, myogenin (Mgn) and MRF4 have been
analysed during the development of chicken embryo somites and limbs. In somites, Myf5 is expressed first in somites
and paraxial mesoderm at HH stage 9 followed by MyoD at HH stage 12, and Mgn and MRF4 at HH stage 14. In
older somites, Myf5 and MyoD are also expressed in the ventrally extending myotome prior to Mgn and MRF4
expression. In limb muscles a similar temporal sequence is observed with Myf5 expression detected first in forelimbs
at HH stage 22, MyoD at HH stage 23, Mgn at HH stage 24 and MRF4 at HH stage 30. This report describes the
precise time of onset of expression of each MRF in somites and limbs during chicken embryo development, and
provides a detailed comparative timeline of MRF expression in different embryonic muscle groups.
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Introduction
The myogenic regulatory factors (MRFs) are a group of four
helix-loop-helix transcription factors that are critical regula-
tors of muscle cell commitment and differentiation in verte-
brates (Pownall et al. 2002; Chanoine et al. 2004; Berkes &
Tapscott, 2005; Tapscott, 2005; Sweetman, 2012). The dis-
covery of MyoD, based on its ability to convert fibroblasts
into muscle cells (Davis et al. 1987), was soon followed by
the identification of other closely related genes that share
this transformative property: Myf5, myogenin (Mgn) and
MRF4 (Braun et al. 1989, 1990; Edmondson & Olson, 1989;
Rhodes & Konieczny, 1989; Wright et al. 1989; Fujisawa-Se-
hara et al. 1990; Miner & Wold, 1990). Together these
genes orchestrate the formation of all skeletal muscle in the
vertebrate embryo.
As these genes have such critical roles in the develop-
ment of muscle, their regulation and expression has been
extensively studied. A series of mouse reporter lines have
been used to uncover a large number of complex interdig-
itated enhancers that regulate Myf5 and MRF4 expression,
which are distributed across 150 kb around these closely
linked loci (Tajbakhsh & Buckingham, 1995; Tajbakhsh
et al. 1996; Summerbell et al. 2000; Carvajal et al. 2001,
2008; Buchberger et al. 2003, 2007; Teboul et al. 2003). In
mammals MyoD expression is primarily controlled by two
enhancers, the core enhancer and distal regulatory region,
which regulate the onset and maintenance of MyoD,
respectively (Goldhamer et al. 1992; Tapscott et al. 1992;
Asakura et al. 1995; Faerman et al. 1995; Chen et al. 2001,
2002; Chen & Goldhamer, 2004), and similar regulatory
sequences have been identified in birds (Pinney et al.
1995). MyoD in turn regulates expression of Mgn and can
interact directly with its promoter to recruit chromatin
remodelling complexes (de la Serna et al. 2005; Armand
et al. 2008; Deato et al. 2008).
Understanding of development has been greatly
informed by the use of the chicken embryo as a model
organism (Tickle, 2004; Davey & Tickle, 2007), and it has
been an exceptionally useful system to understand the
developmental signals that regulate myogenesis in different
embryonic domains, such as the epaxial myotome (M€unster-
berg et al. 1995; Borycki et al. 1998; Schmidt et al. 2000),
the hypaxial myotome (Dietrich et al. 1998; Dietrich, 1999)
and the developing limb (Dietrich et al. 1999; Delfini et al.
2000; Edom-Vovard et al. 2001; Marics et al. 2002; Geetha-
Loganathan et al. 2005; Mok et al. 2014).
However, the existing literature does not comprehen-
sively define the stages and expression patterns of each
MRF during early somite and limb development in chicken
embryos, although this has been done for the head muscu-
lature (Noden et al. 1999). To address this, the expression of
each MRF has been compared in somites and limb using
in situ hybridisation to delineate the relative timings and
expression domains of each of these genes.
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Materials and methods
Dig-labelled probes for in situ hybridisation were generated and
used as described (Sweetman et al. 2008). Fertilised white leghorn
eggs were obtained from Henry Stewart (Norfolk) and incubated to
reach the desired stage.
Briefly, embryos were collected, staged (Hamburger & Hamilton,
1951), fixed in 4% paraformaldehyde (PFA) at 4 °C overnight then
dehydrated by washing in 50% methanol/phosphate-buffered sal-
ine (PBS) with 0.1% Tween (PBSTw) then twice with 100% metha-
nol and stored at 20 °C. Embryos were rehydrated by washing in
75%, 50% and 25% methanol/PBSTw then washed twice in PBSTw.
Embryos older than HH stage 20 were treated with proteinase K in
PBST at 10 lg mL1 for 25 min, then rinsed twice in PBST and fixed
in 4% PFA/0.1% glutaraldehyde for 20 min at room temperature
followed by two washes in PBSTw. Embryos were then washed in 1
: 1 PBSTw : hyb solution (50% formamide, 1.3 9 SSC pH 5, 5 mM
EDTA, 50 lg mL1 yeast RNA, 0.2% Tween-20, 0.5% CHAPS, 100
lg mL1 heparin), washed with hyb solution for 10 min, then incu-
bated in fresh hyb solution incubate at 65 °C for at least 2 h. Probes
in pre-warmed hyb solution at 65 °C were added and incubated
overnight at 65 °C.
Embryos were rinsed twice in hyb solution at 65 °C, washed for
10 min in hyb buffer at 65 °C, then washed twice for 30 min in
washing buffer (50% formamide, 1 9 SSC pH 5, 0.1% Tween-20) at
65 °C. Embryos were washed for 10 min at 65 °C in 1 : 1 washing
buffer : MABT (100 mM maleic acid, 150 mM NaCl, 0.1% Tween-20,
pH 7.5), rinsed three times in MABT, and washed twice for 30 min
in MABT. They were then blocked in 2% Roche blocking reagent
(cat no. 11096176001) in MABT for 1 h, then in 2% Roche blocking
reagent/20% goat serum in MABT for 4 h. Anti-Dig-AP Fab frag-
ments (Roche, cat no. 11093274910) were diluted 1 : 2000 in 2%
Roche blocking reagent/20% goat serum in MABT and incubated
overnight at 4 °C.
Embryos were washed three times for 1 h in MABT and then
twice for 10 min in NTMT (100 mM NaCl, 100 mM Tris pH 9.5, 50 mM
MgCl2, 1% Tween-20). Colour was developed with 9 lL NBT (4-nitro
blue tetrazolium chloride at 75 mg mL1 in 70% dimethylforma-
mide) and 7 lL BCIP (5-bromo-4-chloro-3-indolyl-phosphate, 4-tolui-
dine salt at 50 mg mL1 in dimethylformamide) mL1 of NTMT.
After the staining reaction, embryos were de-stained in high deter-
gent mix, 5 9 TBST (for 100 mL of a 5 9 solution: 4 g NaCl, 12.5 mL
1 M Tris-HCl pH 7.5, 0.1 g KCl, 5 mL Tween-20) to reduce back-
ground and, if required, re-stained.
For sectioning, embryos were dehydrated through 50%, 70%,
90% and 100% ethanol, washed in xylene them embedded in par-
affin wax. Sections (10 lm) were cut, dewaxed in xylene and
mounted in Depex for imaging.
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Fig. 1 Expression of MRFs in early somite stage embryos. At HH stage
10, Myf5 is expressed in somites 1–6 (A), while MyoD (B), Mgn (C)
and MRF4 (D) are not detected. At HH stage 12, Myf5 is expressed in
somites 1–10 (E), MyoD in somites 1–5 (F), but Mgn (G) and MRF4 (H)
are still not expressed. At HH stage 14, Myf5 is expressed in somites
1–21 and in the presegmented mesoderm that will form the next
somite (I). MyoD is expressed in somites 1–18 (J), Mgn in somites
1–10 (K) and MRF4 in somites 1–8 (L). At HH stage 16, Myf5 (M) is
expressed in all somites and the presegmented mesoderm that will
form the next somite, I, MyoD (N) is expressed in somites 1–24, Mgn
in somites 1–20 (O) and MRF4 in somites 1–20 (P).
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Results
Expression in somites from HH stages 9 to 14
Myf5 expression is first detected at HH stage 9 (6–8 somites)
in the medial somite adjacent to the neural tube. Expression
was observed in somites 1–6 in embryos with 7 and 8 som-
ites, but Myf5 expression was not observed in embryos ear-
lier than this. At HH stage 10, expression is seen in the
anterior somites 1–6 (Fig. 1A), while the other MRFs are not
expressed (Fig. 1B–D).
At HH stage 12 (14–16 somites), Myf5 is detected in all
somites and, in some cases, paraxial mesoderm (Fig. 1E).
MyoD was not detected in 14-somite embryos but was in
somites 1–8 in 2/5 15-somite embryos and 16-somite embryos
(Fig. 1F), while Mgn and MRF4 are expressed in anterior
somites, respectively (Fig. 1G,H). The staining of Mgn and
MRF4 observed at these stages is variable.Mgn is detected in
5/10 16-somite embryos: in two of these expression is seen in
the two most anterior somites, in the other three of the four
most anterior somites are stained. Similarly, in 16-somite
embryos MRF4 is seen in 7/11 embryos: two have expression
in somites 1–4, four in somites 1–6 and one in somites 1–8.
At HH stage 14 (20–22 somites), strong Myf5 expression is
seen in all somites and in somite position I, the region
where a new somite is about to form. Posterior somites
show Myf5 restricted to the medial somites, while in more
anterior somites expression is expanded through the whole
medial–lateral extent.MyoD expression at this stage is seen in
somites 1–18 and, like Myf5, is restricted to the medial region
in more posterior somites but is more widespread in anterior
somites (Fig. 1J), while Mgn and MRF4 are now detected in
somites 1–10/12 (Fig. 1K,L). Again there is some heterogeneity
in the expression of Mgn and MRF4 at these stages and, at a
given somite number, differences in the staining pattern of
up to two somites either more or less are observed.
At HH stage 16 (26–28 somites),Myf5 is seen in all somites
and in the paraxial mesoderm that is about to form a new
somite, and MyoD is detected in all but the most recently
formed somites (Fig. 1M,N), while Mgn (Fig. 1O) and MRF4
are expressed in somites 1–20 (Fig. 1P). As is seen at earlier
stages, there is a degree of variability in this staining and
some embryos will have one additional somite expressing
eitherMgn orMRF4.
Notably, Myf5 expression in the medial segmental plate
mesoderm, where the next somite will form, position I, is
not observed in all embryos examined at these stages
(Fig. 1I,M). This was observed in 2/11 embryos at HH stage
8, 1/17 embryos at HH stage 9, 2/12 embryos at HH stage 10,
7/18 embryos at HH stage 11, 8/24 embryos at HH stage 12,
and 6/11 embryos at HH stage 13 (see Fig. S1).
Transverse sections of HH stage 16 embryos show distinct
localisation of MRF transcripts. In anterior somites Myf5 is
expressed in the dorso-medial and ventero-lateral lips of
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Fig. 2 Transverse sections of HH stage 16 embryos stained with MRFs. In somites 5, 10 and 20, Myf5 is expressed in the dorso-medial lip of
the dermomyotome as well as the whole of the myotome including both epaxial and hypaxial domains (A–C). In somite 24, expression of
Myf5 is only seen in the dorso-medial lip and the epaxial myotome (D). In somite position I, Myf5 is expressed in the medial presegmented
mesoderm directly adjacent to the medial neural tube (E). MyoD is expressed in the epaxial and hypaxial in somites 5 and 10 myotome
(F, G), and in more posterior somites this is restricted to the dorsal most region of the epaxial myotome (H, I). Mgn is expressed in both
epaxial and hypaxial domains of anterior somites (J, K), and the epaxial myotome of somite 20 (L) but not in somite 24 (M), while MRF4 (N–
Q) is expressed in the epaxial myotome of somites 5, 10 and 20. dm, dermomyotome; dml, dorso-medial lip of the dermomyotome; ep, ep-
axial myotome; hyp, hypaxial myotome; nc, notochord; nt, neural tube; sp, segmental plate; vll, ventro-lateral lip of the
dermomyotome.
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the dermomyotome, and throughout both the epaxial and
hypaxial myotome that lies directly under the dermomyo-
tome (Fig. 2A–C). In more posterior regions (i.e. somite 15),
Myf5 is only detected in the dorso-medial lip of the dermo-
myotome and forming epaxial myotome (Fig. 2D). In the
segmental plate Myf5 expression is found in the medial
unsegmented paraxial mesoderm immediately adjacent to
the neural tube (Fig. 2E).
MyoD in anterior somites is expressed throughout the
myotome but not the dermomyotome (Fig. 2F–H), and in
more posterior somites this is restricted to the dorso-medial
region of the myotome. In contrast to Myf5, MyoD is not
detected in the dorso-medial or ventro-lateral lips of the
dermomyotome.
Mgn is also expressed only in the myotome and not the
dermomyotome, although it is restricted to the central
domain in anterior somites and does not extend as far into
the ventro-lateral myotome asMyoD (Fig. 2J–M).
MRF4 is also only expressed in anterior somites, but is only
seen in the dorso-medial part of the myotome (Fig. 2N–P)
and does not extend into the ventro-lateral myotome as far
as eitherMyoD orMgn at equivalent stages.
Expression in somites from HH stage 20 to HH stage
26
Sections through older embryos (HH stage 20 to HH stage
26) at interlimb levels (i.e. between somites 22 and 25) show
the myotome extending ventrally to form the trunk mus-
cles. At HH stage 20, both Myf5 and MyoD are expressed
throughout the myotome (Fig. 3A,E), while Mgn and MRF4
are expressed in a more restricted dorsal myotomal domain
(Fig. 3I,M). At HH stage 22 and 24, Myf5, MyoD and Mgn
are expressed in the ventrally extending myotome (Fig. 3B,
C,F,G,J,K), while MRF4 is still only expressed in the dorsal
myotome. By HH stage 26, all four MRFs are expressed
throughout the entire myotome (Fig. 3D,H,L,P).
Expression in limb muscles
The muscles of the limb are derived from somitic migratory
muscle precursors that express the transcription factors
Pax3 and Lbx (Dietrich, 1999; Otto et al. 2006). These cells
delaminate from the ventro-lateral lip of the dermomyo-
tome then migrate into the developing limb where they
form the dorsal and ventral muscle masses. Only at this
point do they begin to express MRFs.
Whole-mount in situ hybridisation shows Myf5 expres-
sion in the forelimb at HH stage 22 (Fig. 4B), with expres-
sion in the hindlimb detected soon after at HH stage 24
(Fig. 4C). In sections, Myf5 can be seen in both dorsal and
ventral muscle masses in the forelimb at HH stage 22
(Fig. 5B), and weak expression can also be seen in hind-
limb myogenic cells (Fig. 6B). Myf5 expression is then
maintained throughout the developing limb muscles at
stages HH stage 24 to HH stage 30 (Figs 4D–F, 5C,D and
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Fig. 3 Transverse sections of somites at limb
bud stages. Myf5 is expressed through the
whole myotome at HH stage 20–26 (A–D), as
are MyoD (E–H) and Mgn (I–L). MRF4 is
expressed only in the central myotome at HH
stage 20 to HH stage 24 (M–O), but
expressed throughout the myotome at HH
stage 26 (P). m, myotome.
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6C,D). At HH stage 30, Myf5 staining becomes less intense,
especially in distal muscles, as differentiation proceeds
(Fig. 4f).
In contrast to Myf5, MyoD expression is first detected in
dorsal and ventral muscle masses in the hindlimb at HH
stage 23 (Fig. 4I), and then in the forelimb at HH stage 24
(Figs 3J, 5G and 6G). Expression is then maintained in the
developing muscles throughout the limb up to HH stage 30
(Figs 4K,L, 5H and 6H).
Mgn is first seen in both fore- and hindlimbs at HH stage
24 (Figs 4P, 5K and 6K), and is then maintained to HH stage
30 (Figs 4Q,R, 5L and 6L).MRF4 is not detected in limb mus-
cles until muscle differentiation is well advanced at HH
stage 30 (Fig. 4W), although some weak staining can be
seen in sections through hindlimbs at HH stage 26 (Fig. 6P).
Concluding remarks
The current data show a clear temporal progression in both
somites and limbs whereMyf5 is expressed first followed by
MyoD. Subsequently, Mgn and MRF4 are expressed with
similar dynamics. This is consistent with current models
in which Myf5 and MyoD are required for myogenic
commitment whileMgn andMRF4 regulate differentiation.
AlthoughMRF4 expression has been reported earlier or con-
temporaneously with Myf5 in mouse somites (Summerbell
et al. 2002) and can act to specify muscles in the absence of
both Myf5 and MyoD (Kassar-Duchossoy et al. 2004), the
current data imply that this function is not conserved in
chicken embryos where MRF4 is only expressed later in
myogenic development.
Expression ofMyf5 in the paraxial mesoderm in HH stages
8–14 in the 1 somite position was also observed. This is
consistent with previous reports that have also observed
Myf5 expression prior to somite formation (Kiefer & Haus-
chka, 2001). However, it is apparent when comparing larger
numbers of embryos at these stages that there is heteroge-
neity in these samples with some embryos showing this
expression and others not. This is observed even in embryos
harvested, processed and stained in a single batch. One pos-
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Fig. 4 MRF expression in developing limbs.
Myf5 is first expressed in the forelimb at HH
stage 22 (A, B), the hindlimb at HH stage 23
(C) and maintained until HH stage 30 (D–F).
MyoD is first expressed in the hindlimb at HH
stage 23 (G–I), then in both limbs to stage
HH stage 30 (J–L). Mgn is first detected in
both fore- and hindlimbs at HH stage 24 (M–
P), and maintained through to HH stage 30
(Q, R), while MRF4 is not detected in limb
buds until HH stage 30 (S–X).
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Fig. 5 Transverse sections through forelimbs.
Myf5 is expressed in both dorsal and ventral
muscle masses from HH stage 22 onwards
(A–D), Myod from HH stage 24 (E–H), Mgn
from HH stage 24 (I–L), while MRF4 is not
detected in limb buds at these stages (M–P).
dmm, dorsal muscle mass; m, myotome;
vmm, ventral muscle mass.
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Fig. 6 Transverse sections through hindlimbs.
Myf5 is expressed in both dorsal and ventral
muscle masses from HH stage 22 onwards
(A–D), Myod from HH stage 24 (E–H), Mgn
from HH stage 24 (I–L). MRF4 is not detected
in limb buds at HH stages 20, 22 and 24 (M–
O), but weak expression can be seen in both
dorsal and ventral muscle masses at HH stage
26 (P). dmm, dorsal muscle mass; m,
myotome; vmm, ventral muscle mass.
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sible explanation is that the in situ protocol produces vari-
able results; however, staining in other tissues, such as the
limbs, is far more reproducible. Therefore, we believe that a
more likely explanation is that they are capturing embryos
at subtly different stages and that those that do not show
this expression have just formed the newest somite and
Myf5 expression is yet to be initiated in the paraxial meso-
derm prior to somite formation. The regulation of Myf5
during development is under the control of a large number
of diverse enhancer elements reviewed in Francetic & Li
(2011), which may help to explain this complex expression
during somitogenesis.
A degree of heterogeneity in the staining of Mgn and
MRF4 in somites between HH stages 12 and 16 was also
observed. This may simply reflect variable efficiency of
staining in different embryos. However, this variability is still
observed in embryos with the same somite number stained
in a single batch, and is not apparent in limb buds where
staining of all probes is highly consistent and reproducible.
There are two possibilities for this: either the current proto-
col does not reliably detect weaker staining in more poster-
ior somites in all cases or there is some variability in the
precise timing of onset of these later MRFs between differ-
ent embryos, possibly because these embryos do not come
from an isogenic inbred line and the difference in time
between stages is small; as new somites are added every 90
min the time between one HH stage and the next is only
4.5 h.
One notable difference between limb and somite staining
is relative timing of Mgn and MRF4 expression. In somites
these genes are expressed at the same point, although the
domain of MRF4 within the myotome is more restricted
than that of Mgn. In contrast, Mgn expression in limb mus-
cles precedes that of MRF4. It is clear that different muscle
groups have different regulatory networks driving their dif-
ferentiation (Mok & Sweetman, 2011), and this may explain
the distinct staining dynamics observed. Also clearly differ-
ent shapes in myotomes at different axial levels are
observed. At limb levels the myotome does not extend
dorso-medially to the same extent as it does in the interlimb
region. This is presumably to facilitate the migration of limb
muscle precursors, although limb level somites do also
produce the pectoral muscles by myotomal extension
(Beresford et al. 1978), so this difference in shape does not
preclude this mode of myogenesis.
It is also apparent that the data presented do not entirely
agree with some previous reports that have detected Myf5
expression in primitive streak at HH stage 3 and paraxial
mesoderm and HH stage 5 (Kiefer & Hauschka, 2001).
Despite extensive staining, expression has not been seen in
these early embryos. This is presumably due to differences
in the staining protocols and probes used, and it may be
that the current approach sacrifices some sensitivity for
specificity.
One intriguing question that remains is to what extent
the myoblasts in a particular region of the embryo are
homogeneous or consist of distinct subpopulations with dif-
ferent characteristics. Previous reports have already identi-
fied differences in the expression domains of Myf5 and
MyoD within the dorsal and ventral muscle masses of the
limb (Delfini et al. 2000), and ablation experiments have
also suggested that there are Myf5-independent (Gensch
et al. 2008; Haldar et al. 2008) but not MyoD-independent
(Wood et al. 2013) myogenic lineages within the embryo,
although this view has been challenged (Comai et al. 2014;
Haldar et al. 2014). However, the current in situ hybridisa-
tions do not provide single cell resolution and distinct pop-
ulations cannot reliably be identified, so the resolution of
this question will require further work.
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